. 2019 Mar 28;16(7):1104. doi: 10.3390/ijerph16071104

Table 1.

Clinical and epidemiologic characteristics of patients whose samples were colonized with association between MDRO and covariates.

Epidemiologic Variable		Total MDRO		VRE			MRSA	CRE		CRAB		CRPA
Epidemiologic Variable		Adjusted OR	95% CI	Adjusted OR	95% CI	Adjusted OR	95% CI	Adjusted OR	95% CI	Adjusted OR	95% CI	Adjusted OR	95% CI
Gender	female	ref.		ref.		ref.		ref.		ref.		ref.
	male	1.23	1.01–1.5 *	1.31	0.48–3.55	1.10	0.85–1.42	1.84	0.98–3.47	1.62	0.95–2.75	1.00	0.58–1.70
Age (years)	<40	ref.		ref.		ref.		ref.		ref.		ref.
	40–59	0.85	0.63–1.16	NA		0.60	0.42–0.84 *	1.88	0.61–5.75	3.13	0.59–16.4	1.49	0.39–5.69
	≥60	1.75	1.37–2.23 *	NA		0.85	0.64–1.14	4.08	1.67–9.96 *	15.8	3.78–66.00 *	7.67	2.98–19.70 *
Sample	Urine	ref.		ref.		ref.		ref.		ref.		ref.
	Pus	9.83	7.52–12.8 *	0.34	0.07–1.57	51.90	31.3–86.00 *	1.29	0.57–2.88	2.39	1.01–5.64*	0.70	0.26–1.88
	Sputum	4.33	3.08–6.10 *	NA		8.51	4.29–16.80 *	0.65	0.23–1.83	6.77	3.33–13.70*	2.29	1.17–4.46 *
	Others	2.73	2.04–3.65 *	0.11	0.01–0.97 *	10.10	5.95–17.10 *	1.14	0.51–2.51	2.02	0.91–4.44	1.13	0.56–2.27
Station	OPD, ER	ref.		ref.		ref.		ref.		ref.		ref.
	ICU, RCW, CNU	2.3	1.65–3.20 *	6.66	1.49–29.70 *	1.62	1.01–2.59 *	3.80	1.08–13.30 *	5.41	2.36–12.40 *	6.28	2.74–14.30 *
	General Ward	1.05	0.84–1.31	1.1	0.85–1.42	0.64	0.49–0.83 *	4.35	1.89–10.00 *	2.01	0.98–4.13	2.40	1.21–4.77 *

MDRO = multidrug-resistant microorganism. VRE = vancomycin-resistant enterococci spp. MRSA = methicillin-resistant staphylococcus aureus. CRE = carbapenem-resistant enterobacteriaceae. CRAB = carbapenem-resistant a. baumannii. CRPA = carbapenem-resistant pseudomonas aeruginosa. Ref. = reference.95% CI = 95% confidence interval. Adjusted OR = adjusted odds ratio. * = p < 0.05.